Skip to main content
SpringerLink
Log in

Diabetes und Krebs – den Zusammenhängen auf der Spur

Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie, 29.09. bis 03.10.2017, Stuttgart

Diabetes and cancer—on the track of the associations

Annual meeting of the German, Austrian and Swiss Societies for Hematology and Medical Oncology, from 29 September to 3 October 2017 in Stuttgart

  • Onkologiekongresse
  • Published:
Der Onkologe Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Literatur

  1. Wang P et al (2012) Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis. Diabetes Metab Res Rev 28(2):109–122

    Article  PubMed  Google Scholar 

  2. Friberg E et al (2007) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50(7):1365–1374

    Article  CAS  PubMed  Google Scholar 

  3. Jing W et al (2012) Diabetes mellitus and increased risk of cholangiocarcinoma: a meta-analysis. Eur J Cancer Prev 21(1):24–31

    Article  PubMed  Google Scholar 

  4. Ben Q et al (2011) Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 47(13):1928–1937

    Article  PubMed  Google Scholar 

  5. Bansal D et al (2013) Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational studies. Prostate Cancer Prostatic Dis 16(2):151–158, S1

    CAS  PubMed  Google Scholar 

  6. Rao Kondapally Seshasai S et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841

    Article  PubMed  PubMed Central  Google Scholar 

  7. Tsilidis KK et al (2015) Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350:g7607

    Article  PubMed  Google Scholar 

  8. Giovannucci E et al (2010) Diabetes and cancer: a consensus report. Diabetes Care 33(7):1674–1685

    Article  PubMed  PubMed Central  Google Scholar 

  9. Rinaldi S et al (2010) Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies. Int J Cancer 126(7):1702–1715

    CAS  PubMed  Google Scholar 

  10. Zhou XH et al (2010) Diabetes, prediabetes and cancer mortality. Diabetologia 53(9):1867–1876

    Article  CAS  PubMed  Google Scholar 

  11. Farmer RE et al (2017) Metformin and cancer in type 2 diabetes: a systematic review and comprehensive bias evaluation. Int J Epidemiol 46(2):728–744

    Article  PubMed  Google Scholar 

  12. Currie CJ et al (2009) The influence of glucose-lowering therapies on cancer risk in type 2 diabetes. Diabetologia 52(9):1766–1777

    Article  CAS  PubMed  Google Scholar 

  13. Carstensen B et al (2012) Cancer occurrence in Danish diabetic patients: duration and insulin effects. Diabetologia 55(4):948–958

    Article  CAS  PubMed  Google Scholar 

  14. Heckman-Stoddard et al (2017) Repurposing metformin for the prevention of cancer and cancer recurrence. Diabetologia. https://doi.org/10.1007/s00125-017-4372-6

    Google Scholar 

  15. Rios Garcia M et al (2017) Acetyl-coA carboxylase 1‑dependent protein acetylation controls breast cancer metastasis and recurrence. Cell Metab. https://doi.org/10.1016/j.cmet.2017.09.018

    PubMed  Google Scholar 

  16. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Prostate Cancer, Version 2.2017–February 21, 2017. www.nccn.org. Zugegriffen: 2. November 2017

Download references

Author information

Authors and Affiliations

  1. Wissenschaftliche Fachkommunikation, Landwehrstr. 31, 80336, München, Deutschland

    Friederike Klein

Authors
  1. Friederike Klein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Friederike Klein.

Ethics declarations

Interessenkonflikt

F. Klein erhielt eine Unterstützung zu den Reisekosten zur Jahrestagung der Deutschen, Österreichischen und Schweizerischen Gesellschaften für Hämatologie und Medizinische Onkologie durch Novartis Pharma GmbH.

Dieser Beitrag beinhaltet keine vom Autor durchgeführten Studien an Menschen oder Tieren. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Klein, F. Diabetes und Krebs – den Zusammenhängen auf der Spur. Onkologe 23, 1016–1020 (2017). https://doi.org/10.1007/s00761-017-0311-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00761-017-0311-x

Search

Navigation